RDDT, a vivoPharm Company Pty Ltd


RDDT – GLP Facility

Accreditation No.


Site No.


Date of Accreditation

10 Jun 2004


CSIRO Clayton, Building 125, Research Way
Clayton South, VIC 3169



Dr Ralf Brandt P: +61 0439433425


Services available to external clients

Scope of Recognition

RDDT – GLP Facility

OECD Principles of Good Laboratory Practice (1997)

  • NATA recognition for compliance with the OECD Principles of GLP covers all non-clinical health and environmental safety studies conducted within Australia for regulatory purposes. Detailed below are the types of studies which have been specifically inspected by NATA. A facility recognised as GLP compliant may claim compliance for any GLP study conducted within Australia.

Healthcare, Pharmaceutical and Media Products

Service Product Determinant
Analytical and clinical chemistry associated with non-clinical studies Medical devices; Pharmaceutical products Histopathology
Pharmaceutical products Analytical chemistry
Clinical pathology
Mutagenicity studies Pharmaceutical products Genotoxicity studies
Toxicity studies Pharmaceutical products Toxicokinetic studies
Acute studies
Subacute and chronic studies

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.